Company Overview and News

13
Cashed-Up Grannies Splurging on Grandkids Boost Japan's Economy - Bloomberg

2018-06-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

13
Rosneft says it is "comfortable" with $70-$80 oil

2018-06-15 worldoil
The producers working together have “restored balance to the market by cutting oil production,” Russia’s biggest oil company said in a statement Friday, citing comments its CEO Igor Sechin made at a meeting in Moscow on Thursday with Saudi Arabia’s energy minister.
DSLV VIIX DGLD CSSLF VIIZ LKOR CS 31KX LKOH CSGKF UGLD LKOE 68FV LKOD GZPFY ZIV USLV LKOB TVIX XIV

50
Credit Suisse (CS) Settles Lawsuit With Lehman for $385M

2018-06-14 zacks
Credit Suisse Group (CS - Free Report) has reached a $385 million settlement with the Lehman Brothers Holdings’ bankruptcy estate over terminated derivatives transactions. The settlement is subject to court’s approval.
DSLV VIIX DGLD CSSLF VIIZ BMO CS BMO CSGKF UGLD LHHMQ BCH ZIV USLV TVIX XIV

13
Cashed-up grannies splurging on grandkids boost Japan’s economy

2018-06-14 japantimes.co.jp
Mikayo Taguchi loves splurging on her grandkids and children, whether for clothes or sporting goods or family outings. In Japan, that generosity matters — boosting demand by tens of billions of dollars each year.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

25
Credit Suisse to Gain From Narrowing of Martin Act Statute

2018-06-13 zacks
Per the latest ruling by the New York State Court of Appeal, the statute of limitations for raising claims under the Martin Act has been contracted to three years instead of six. The 4-to-1 decision by New York’s highest court is likely to grant victory to Credit Suisse Group AG (CS - Free Report) as it tries to end an $11 billion mortgage securities fraud lawsuit filed against it in 2012. The Martin Act is an anti-fraud law under which the New York’s Attorney General has powers to conduct investigations of securities fraud and hence, bring civil or criminal actions against alleged violators.
DSLV VIIX DGLD CSSLF VIIZ BMO CS BMO CSGKF UGLD BCH ZIV USLV TVIX XIV

16
PRESS DIGEST- New York Times business news - June 13

2018-06-13 reuters
June 13 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy.
DSLV VIIX DGLD CSSLF VIIZ GES TWX NYTAB TWC CS CSGKF UGLD ZIV USLV TVIX XIV

13
Credit Suisse Is Said to Cut Senior Investment-Banking Jobs

2018-06-12 theedgemarkets
(June 13): Credit Suisse Group AG has been cutting senior investment-banking jobs as the Swiss bank reorganizes its European advisory business to boost profitability, according to three people with knowledge of the matter.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

13
New York's top court narrows Martin Act in $11 bln Credit Suisse case

2018-06-12 reuters
NEW YORK (Reuters) - New York State’s highest court on Tuesday narrowed the reach of a powerful law used by the state’s attorney general to fight financial fraud, handing a partial victory to Credit Suisse Group AG (CSGN.S) in an $11 billion lawsuit over defective mortgage securities.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

409
China phone giant Xiaomi may be twice as expensive as Apple

2018-06-12 malaymail
HONG KONG, June 12 — Chinese serial entrepreneur Lei Jun has been compared with Steve Jobs. Now, analysts are saying the smartphone giant he built could be twice as expensive as Apple Inc.
FIT DB DGLD GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA CS GS UGLD GLSSP AAPL MS BIDU JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI GPRO CSGKF BABA MS.PRI GS.PRD MS.PRK GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

13
MOVES-Credit Suisse appoints two SEAsia investment banking execs

2018-06-12 reuters
(Reuters) - Credit Suisse Group AG (CSGN.S) on Tuesday appointed Yvonne Voon and Felicity Chan in its Southeast Asia investment banking business to strengthen its franchise in the region.
CSGKF UGLD DSLV VIIX DGLD CSSLF VIIZ ZIV USLV TVIX CS XIV

107
Chinese smartphone giant Xiaomi could be twice as expensive as Apple

2018-06-12 scmp
Xiaomi, which has been planning to raise about US$10 billion, is reportedly considering getting about half that amount from its Hong Kong IPO and the other half from an offering in mainland China
DSLV DB VIIX DGLD CSSLF VIIZ MS.PRE MS.PRF MS.PRG MS.PRA CS CSGKF BABA UGLD MS.PRI MS.PRK ZIV USLV MS TVIX XIV

408
Chinese phone giant Xiaomi could be twice as expensive as Apple

2018-06-12 malaymail
BEIJING, June 12 — Chinese serial entrepreneur Lei Jun has been compared with Steve Jobs. Now, analysts are saying the smartphone giant he built could be twice as expensive as Apple Inc.
FIT DB DGLD GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA CS GS UGLD GLSSP AAPL MS BIDU JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI GPRO CSGKF BABA MS.PRI GS.PRD MS.PRK GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

409
Xiaomi could be twice as expensive as Apple

2018-06-12 livemint
Hong Kong: Chinese serial entrepreneur Lei Jun has been compared with Steve Jobs. Now, analysts are saying the smartphone giant he built could be twice as expensive as Apple Inc.
FIT DB DGLD GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA CS GS UGLD GLSSP AAPL MS BIDU JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI GPRO CSGKF BABA MS.PRI GS.PRD MS.PRK GS.PRC ZIV USLV GJS TVIX GS.PRN GS.PRK XIV

70
UBS family office unit targets Asia's new billionaire dealmakers

2018-06-12 theedgemarkets
ZURICH (June 12): UBS Group AG expects most new family-office clients to come from Asia as global banking rivals compete to manage funds and broker deals for the world’s wealthiest clans.
DGLD GS.PRB GS.PRA CS GS UGLD GLSSP UBS UBS.PRDCL JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG GSJ GS.PRJ GS.PRI CSGKF GS.PRD GS.PRC ZIV USLV GJS TVIX GS.PRN ULSGF GS.PRK XIV

94
It’s billionaires at the gate as ultra-rich muscle in on private equity

2018-06-12 theedgemarkets
NEW YORK (June 12): America’s last Gilded Age had its “List of 400”: the people said to be worthy enough, or at least rich enough, to climb the pinnacles of high society.
SNHFY DB DGLD GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG MS.PRA CS GS GLSSP UGLD UBS UBS.PRDCL TIME MS JBK DSLV VIIX GSC GS.PRICL CSSLF VIIZ TFG MDP GSJ GS.PRJ GS.PRI CSGKF MS.PRI GS.PRD MS.PRK GS.PRC SNHFF MDPEB ZIV USLV TVIX GS.PRN GJS ULSGF GS.PRK XIV

Related Articles

ARWR: Arrowhead Pharmaceuticals Analysis and Research Report

3h - Asif

Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...

PRTO: Proteon Therapeutics Analysis and Research Report

2018-06-11 - Asif

Overview Proteon Therapeutics is a late-stage biopharmaceutical company focused on the development of novel, first-in-class pharmaceuticals to address the needs of patients with renal and vascular disease. The company's product candidate, vonapanitase, is a recombinant human elastase that Proteon Therapeutics is developing to improve vascular access outcomes in patients with chronic kidney disease, or CKD, undergoing or planning for hemodialysis, a lifesaving treatment that cannot be conducted without a functioning vascular access. The company believe data from its completed Phase 2 and Phase 3 clinical trials of vonapanitase support that a one-time, local application of investigational vonapanitase during surgical creation of a radiocephalic fistula for hemodialysis may improve fistula use for hemodialysis and secondary patency (time to fistula abandonment), thereby improving patient outcomes and reducing the burden on patients and the healthcare system. Arteriovenous fistu...

GALE: Galena Biopharma Analysis and Research Report

2018-06-11 - Asif

Overview Galena Biopharma is a clinical-stage biopharmaceutical company focused on novel cancer immunotherapeutics for a broad range of cancer indications. The company's lead product candidate, galinpepimut-S, or GPS, is a cancer i unotherapeutic agent licensed from Memorial Sloan Kettering Cancer Center, or MSK, that targets the Wilms tumor 1, or WT1, protein, which is present in 20 or more cancer types. Based on its mechanism of action as a directly immunizing agent, GPS has the potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic, or blood, cancers and solid tumor indications. Phase 2 clinical trials for GPS have been completed and Galena Biopharma has planned Phase 3 clinical trials (pending funding availability) for two indications, acute myeloid leukemia, or AML, and malignant pleural mesothelioma, or MPM. GPS is also in development as a potential treatment for multiple myeloma, or MM, and ovarian can...

CUSIP: 22542D662